Sensyne, Oxford University deploy AI to find asthma targets

Oxford University and UK clinical artificial intelligence (AI) company Sensyne Health will partner on a project to find new drug targets for people with hard-to-treat asthma.

AI tool looks to provide personalised COVID care

Microsoft and UK clinical AI company Sensyne Health will use their SENSE clinical algorithms to help provide more personalised care for COVID-19 patients as part of a new agreement with Chelsea

Sensyne launches ‘good neighbour’ app to monitor COVID-19

AI-powered study backs anticoagulants for heart failure pati...

A new study has found that blood thinning drugs improve outcomes for all heart failure patients, regardless of whether they already have atrial fibrillation (AF).

Bayer chooses UK for its AI-focused R&D hub

UK AI firm Sensyne makes inroads into US health market

The UK clinical artificial intelligence (AI) firm Sensyne has announced agreements with a Fortune 200 company, and a data infrastructure specialist, to launch and grow its digital health pr